General Information of the Compound
| Compound ID |
CP0461305
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[3-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]propyl]imidazo[1,2-a]pyridine-3-sulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H24N6O2S2
|
||||||||||||||||||
| Molecular Weight |
456.597
|
||||||||||||||||||
| Canonical SMILES |
O=S(=O)(NCCCN1CCN(CC1)c1nsc2ccccc12)c1cnc2ccccn12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H24N6O2S2/c28-31(29,20-16-22-19-8-3-4-11-27(19)20)23-9-5-10-25-12-14-26(15-13-25)21-17-6-1-2-7-18(17)30-24-21/h1-4,6-8,11,16,23H,5,9-10,12-15H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
YXPPQEAUYCKYSO-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7
Protein ID: PT01005, D(2) dopamine receptor